Skip to main content
Clinical Trials/NCT01549691
NCT01549691
Completed
Phase 4

Assessment of Two Modes of Premedication in Surgery - PREMED Study

University Hospital, Angers8 sites in 1 country455 target enrollmentMarch 2012

Overview

Phase
Phase 4
Intervention
Zopiclone
Conditions
Anxiety
Sponsor
University Hospital, Angers
Enrollment
455
Locations
8
Primary Endpoint
anxiety scales
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

The purpose of this study is to test the level of anxiety in patients, the day before surgery (late afternoon) and immediately prior to surgery in 3 parallel groups of patients.

  • one receiving placebo before going to sleep (before sleep), the day prior surgery and placebo when awakening (awakening), the day of surgery
  • one receiving zopiclone (7.5 mg) before sleep and placebo at awakening
  • one receiving placebo before sleep and alprazolam (0.5 mg)at awakening

double blind, randomized controlled study

Detailed Description

Eligibility: * 18 to 65 years old * elective surgery * in-hospital preoperative night Outcome measures: * anxiety scales * demographic data

Registry
clinicaltrials.gov
Start Date
March 2012
End Date
April 2013
Last Updated
12 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
University Hospital, Angers
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • age 18-65 years old
  • elective surgery
  • in-hospital night before surgery

Exclusion Criteria

  • myasthenia gravis
  • chronic intake of psychotropic drugs
  • opiates intake
  • severe obstructive sleep apnea
  • intracranial hypertension
  • morbid obesity
  • myasthenia gravis
  • acute severe medical disorder
  • non health insurance coverage
  • protected patients by law

Arms & Interventions

zopiclone

zopiclone given before sleep, the day before surgery (placebo given at awakening the day of surgery)

Intervention: Zopiclone

alprazolam

given at awakening, the day of surgery (placebo given before sleep, the day before surgery)

Intervention: Alprazolam

placebo

Placebo given night before operation and the morning of operation

Intervention: placebo

Outcomes

Primary Outcomes

anxiety scales

Time Frame: duration of the study : 12 hours (one evaluation on late afternoon the day before surgery and the second evaluation on arrival to operating room)

\* The day before surgery (late afternoon) : patient's self rating of anxiety and desire of information regarding upcoming surgery (Amsterdam patient anxiety and information scale, APAIS) \* On arrival to the operating room : Recording of the level of declared anxiety (numeric scale similar to that corresponding of the "anxiety component of the APAIS scale)

Secondary Outcomes

  • markers of stress(on arrival to operating room (one single recording))

Study Sites (8)

Loading locations...

Similar Trials